Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17526539 | 1.00 | LMNA (0.56) | LMNAALDH1A1TSHRBLMPTPN1 | |
| SCHEMBL11110163 | 0.95 | LMNA (0.62) | LMNAALDH1A1TSHRBLMPTPN1 | |
| SCHEMBL17526784 | 0.95 | LMNA (0.62) | LMNAALDH1A1TSHRBLMPTPN1 | |
| SCHEMBL17526637 | 0.95 | LMNA (0.62) | LMNAALDH1A1TSHRBLMPTPN1 | |
| SCHEMBL17526548 | 0.93 | LMNA (0.67) | LMNAALDH1A1TSHRBLMCYP3A4 | |
| SCHEMBL17526404 | 0.93 | LMNA (0.67) | LMNAALDH1A1TSHRBLMCYP3A4 | |
| SCHEMBL17526924 | 0.91 | ALDH1A1 (0.62) | LMNAALDH1A1TSHRBLMPTPN1 | |
| SCHEMBL4605043 | 0.91 | ALDH1A1 (0.62) | LMNAALDH1A1TSHRBLMPTPN1 | |
| SCHEMBL14700022 | 0.87 | LMNA (0.64) | LMNAALDH1A1TSHRBLMCYP3A4 | |
| SCHEMBL10878919 | 0.87 | LMNA (0.56) | LMNAALDH1A1TSHRBLMPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160039879-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | S&T GLOBAL INC. (US) | 2016-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160039879-A1 | NOVEL CYCLOSPORIN DERIVATIVES AND USES THEREOF | FKBP1B, MALT1, FKBP5 | LMNA 3497/4885ALDH1A1 2376/4885TSHR 4131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.